阿尔法-2A-上腺素受体基因多态化调节灰色物质结构网络,视觉记忆和注意力缺陷/多动症儿童的抑制性认知控制
Ying Chen1, Hengyi Cao2,3, Nanfang Pan1
1Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular lmaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610065, China.
Cerebral cortex (New York, N.Y. : 1991)
|June 13, 2023
概括
ADRA2A G/G基因型对患有注意力缺陷多动症 (ADHD) 的儿童的大脑网络产生影响,影响视觉记忆和抑制控制. 这些发现将特定的基因变异与ADHD中的大脑结构和认知功能联系起来.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 发展心理学 发展心理学
背景情况:
- 注意缺陷多动症 (ADHD) 与ADRA2A-1291C>G多态性和认知缺陷有关.
- 了解基因-大脑-行为关系对于ADHD研究至关重要.
研究的目的:
- 调查ADRA2A G/G基因型是否影响ADHD的灰质 (GM) 网络.
- 确定这些基因-大脑调制是否与ADHD的认知功能相关.
主要方法:
- 招募了75名从未使用过药物的ADHD儿童和70名健康对照.
- 使用基于面积相似性的图形理论分析了GM网络.
- 使用标准测试评估视觉记忆和抑制控制,并进行SNP基因定型.
主要成果:
- 观察到ADHD诊断和ADRA2A基因多态性在特定的大脑区域 (左下叶,左下额头) 之间有显著的相互作用.
- 在患有G/G基因型的ADHD儿童中,左下额头回中发现节点效率下降.
- 在ADRA2A调节的网络变化与视觉记忆和抑制性控制受损之间有明显的联系.
结论:
- 在ADHD中发现基因-大脑-行为关联的新证据.
- 灰质网络的改变,特别是在前对对联环中,与具有ADRA2A-G/G基因型的多动症儿童的认知缺陷有关.
相关概念视频
Attention-Deficit/Hyperactivity Disorder
133
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
133
Human Genetics
628
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
628
Adrenergic Receptors: ɑ Subtype
1.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.6K
Adrenergic Receptors (Adrenoceptors): Classification
2.7K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.7K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K


